Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Complications of massive transfusion Sihler KC; Napolitano LMChest 2010[Jan]; 137 (1): 209-20Massive transfusion (MT) is a lifesaving treatment of hemorrhagic shock, but can be associated with significant complications. The lethal triad of acidosis, hypothermia, and coagulopathy associated with MT is associated with a high mortality rate. Other complications include hypothermia, acid/base derangements, electrolyte abnormalities (hypocalcemia, hypomagnesemia, hypokalemia, hyperkalemia), citrate toxicity, and transfusion-associated acute lung injury. Blood transfusion in trauma, surgery, and critical care has been identified as an independent predictor of multiple organ failure, systemic inflammatory response syndrome, increased infection, and increased mortality in multiple studies. Once definitive control of hemorrhage has been established, a restrictive approach to blood transfusion should be implemented to minimize further complications.|*Blood Coagulation[MESH]|*Transfusion Reaction[MESH]|Blood Coagulation Disorders/blood/*etiology[MESH]|Blood Transfusion/mortality[MESH]|Humans[MESH]|Multiple Organ Failure/blood/*etiology[MESH]|Prognosis[MESH]|Risk Factors[MESH]|Shock, Hemorrhagic/*therapy[MESH]|Survival Rate[MESH]|Systemic Inflammatory Response Syndrome/blood/*etiology[MESH]|Thrombocytopenia/blood/*etiology[MESH] |
